EKF Diagnostics Showcases Specialized POC Medical Diagnostic and Lab Solutions

EKF Diagnostics (Cardiff, Wales, UK) is showcasing its specialized range of point-of-care medical diagnostic and laboratory solutions at ADLM 2025.

EKF delivers diagnostic technologies and biotechnology solutions, empowering healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications. Visitors to the EKF booth at ADLM 2025 can discover the DiaSpect Tm hand-held hemoglobin analyzer and the Hemo Control hemoglobin testing and hematocrit estimation device, which are designed to provide quick, reliable, and accurate results in diverse healthcare settings. EKF is also presenting the STAT‑Site WB, which provides rapid and precise quantitative results for β-ketone and glucose measurements, and the Beta-Hydroxybutyrate LiquiColor reagent, a quantitative FDA-cleared test for detecting ketones and monitoring diabetic ketoacidosis.

Image: EKF’s cutting-edge point-of-care diagnostic solutions are on display at ADLM 2025 (Photo courtesy of EKF Diagnostics)

Visitors interested in connectivity solutions can explore EKF Link, the company’s versatile software platform that connects point-of-care devices seamlessly to hospital and laboratory IT systems. The flexible, open data management solution that seamlessly integrates with most vendors’ point-of-care analyzers, allowing real-time management of patient test results, quality control (QC) data, operator management, and analyzer configuration. Designed to provide a flexible and secure method for connecting point-of-care devices to hospital and laboratory IT systems, EKF Link enables the transfer of data from the analyzer to the hospital or laboratory database for subsequent processing.

Related Links:
EKF Diagnostics